GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Glaukos Corp (FRA:6GJ) » Definitions » Other Current Liabilities

Glaukos (FRA:6GJ) Other Current Liabilities : €21.0 Mil (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Glaukos Other Current Liabilities?

Glaukos's other current liabilities for the quarter that ended in Dec. 2024 was €21.0 Mil.

Glaukos's quarterly other current liabilities declined from Jun. 2024 (€19.9 Mil) to Sep. 2024 (€19.2 Mil) but then increased from Sep. 2024 (€19.2 Mil) to Dec. 2024 (€21.0 Mil).

Glaukos's annual other current liabilities increased from Dec. 2022 (€16.3 Mil) to Dec. 2023 (€18.9 Mil) and increased from Dec. 2023 (€18.9 Mil) to Dec. 2024 (€21.0 Mil).


Glaukos Other Current Liabilities Historical Data

The historical data trend for Glaukos's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glaukos Other Current Liabilities Chart

Glaukos Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.89 15.06 16.26 18.88 21.03

Glaukos Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.88 11.22 19.87 19.22 21.03

Glaukos Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


Glaukos Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Glaukos's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Glaukos Business Description

Traded in Other Exchanges
Address
One Glaukos Way, Aliso Viejo, CA, USA, 92656
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Glaukos Headlines

No Headlines